Publication | Closed Access

Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation

Hematological MalignancyHdac InhibitorsMixed-phenotype Acute LeukemiaGene Body DemethylationMalignant Blood DisorderHematologyMyeloid NeoplasiaCombination TreatmentAdult T-cell Leukemia-lymphomaRadiation OncologyMedicineCell BiologyEpigeneticsHealth Sciences